当前位置: X-MOL 学术J. Biomed. Mater. Res. Part A › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Immunoengineering has arrived
Journal of Biomedical Materials Research Part A ( IF 3.9 ) Pub Date : 2020-06-25 , DOI: 10.1002/jbm.a.37041
Jordan J Green 1, 2
Affiliation  

Immunoengineering is a new discipline that creates and applies engineering tools and principles to investigate and modulate the immune system. It spans from the molecular scale to the scale of populations and is critically important in both health and disease. This perspective discusses the rapid development of immunoengineering as a field, including advances to research and education. On the research side, immunoengineering is poised to revolutionize technologies for tissue engineering, drug delivery, and medical devices, among others. Immunoengineering is shown to unlock new tools for biomedical discovery and innovation and has the potential to safely and effectively treat myriad diseases, from cancer to infectious diseases to type 1 diabetes and autoimmune diseases in novel ways. On the educational side, it is described how immunoengineering centers and educational focus areas are being created at leading universities. Furthermore, data are presented to show how grant agencies are making major investments into the field and high‐impact research and translational biotechnologies are being developed.

中文翻译:

免疫工程已经到来

免疫工程是一门新学科,它创造和应用工程工具和原理来研究和调节免疫系统。它涵盖从分子规模到人口规模,对健康和疾病都至关重要。这一观点讨论了免疫工程作为一个领域的快速发展,包括研究和教育的进展。在研究方面,免疫工程有望彻底改变组织工程、药物输送和医疗设备等技术。免疫工程被证明可以开启生物医学发现和创新的新工具,并有可能以新颖的方式安全有效地治疗从癌症到传染病再到 1 型糖尿病和自身免疫性疾病的无数疾病。在教育方面,它描述了领先大学如何创建免疫工程中心和教育重点领域。此外,还提供了数据以显示资助机构如何对该领域进行重大投资,以及正在开发高影响力的研究和转化生物技术。
更新日期:2020-06-25
down
wechat
bug